Skip to main content
 This program is not active.
Not Found
Digital Seminar

Advances in the Management of ADHD: Evidence-Based Medications and Psychosocial Treatments

The past 10-15 years have witnessed a number of major developments in the medications and delivery systems available for the management of ADHD.  Dr. Russell Barkley discusses the types of medications now available for ADHD management and the various delivery systems developed to extend the effectiveness of the medications across the day.  For each medication, he will present the major beneficial effects and side effects.  He will also discuss various issues clinicians should consider in selecting medications to use with a patient with ADHD, such as those issues related to the social context, the patient’s characteristics, and any comorbid conditions that may exist. 

This recording then moves on to an overview of the science-based approaches to the psychosocial management of ADHD.  It also discusses those treatments that, while popular, have little evidence for their effectiveness in managing the disorder. 

Details

Product Details
Average Rating:
   8
Faculty:
Russell Barkley, PhD
Duration:
3 Hours
Format:
Audio and Video
Copyright:
Aug 28, 2018
Product Code:
POS052584
Media Type:
Digital Seminar
Access:
Never expires.

CPD

Continuing Professional Development Certificates
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 3.0 hours CPD.

Handouts

File type File name Number of pages
PDF Manual - Advances in the Management of ADHD (2.25 MB) Available after Purchase

Faculty

Russell Barkley, PhD's Profile

Russell Barkley, PhD Related seminars and products

Russell A. Barkley, PhD, recently retired (January 1, 2022) from his position as a Clinical Professor of Psychiatry at Virginia Commonwealth University School of Medicine (2016-present). He is also a retired Professor of Psychiatry and Neurology from the University of Massachusetts Medical Center (1985-2002) and subsequently worked as a Professor of Psychiatry and Health Sciences at the Medical University of South Carolina (2003-2016). Dr. Barkley is the founder and Editor of the clinical newsletter, The ADHD Report, which he continues to edit in this 30th and final year of publication (2022). He is board certified in Clinical Psychology (ABPP), Clinical Child and Adolescent Psychology, and Clinical Neuropsychology (ABCN, ABPP).

Dr. Barkley is a clinical scientist, educator and practitioner who has published 27 books, rating scales, and clinical manuals numbering more than 43 editions, and creator of 7 award winning professional videos. He has published more than 300 scientific articles and book chapters related to the nature, assessment, and treatment of ADHD and related disorders and is the author of the book Managing ADHD in School (PESI, 2016).

Dr. Barkley has presented more than 800 invited lectures in more than 30 countries and appeared on nationally televised shows such as 60 Minutes, the Today show, Good Morning America, CBS Sunday Morning, CNN, and many others. He has received numerous awards from professional societies and ADHD organizations for his lifetime achievements, contributions to research and clinical practice, and the dissemination of science.

Speaker Disclosures
Financial: Dr. Russell Barkley receives royalties as a published author. He previously received a speaking honorarium from Astra Zeneca and Takeda Pharmaceutical Company. Dr. Barkley receives royalties from ContinuingEdCourses.net and a speaking honorarium from Ochsner Medical Center and Medical College of Wisconsin. He receives a speaking honorarium, recording, and book royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Russell Barkley is a member of the American Psychological Association, the South Carolina Psychological Association, and the American Professional Society for ADHD and Related Disorders.

Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Assess and characterize the utility of current FDA approved ADHD management medications for symptom management
  2. Discriminate between effective and unproven adjunctive ADHD interventions and its treatment implications
  3. Articulate the beneficial effects and potential side effects associated with ADHD medications in relation to assessment and treatment planning

Outline

Purpose of medication interventions

  • Stimulant medications most effective and well researched ADHD interventions
  • Safety, convenience and cost effectiveness are well established
Mechanisms of action for the three categories of ADHD medications Neurobiological mechanism of operation
  • Traditional stimulants as compared to new alpha-2a receptor conceptualizations
Primary US approved stimulant medications
  • Efficacy and factors in noncompliance
  • New developments in delivery systems 
  • OROS, Pulse delivery, transdermal, lisdexamfetamine
Stimulant efficacy in preschoolers
  • Gains smaller, side effects greater than in older children
Behavioral benefits of stimulant interventions
  • Academic, temperamental
Primary side effects of stimulant interventions
  • Insomnia, appetite suppression, head ache, gastric distress, cardiac effects
Common misconceptions related to stimulant use Predictors of positive response to medications Newer medication interventions
  • Atomoxetine – positive and side effects, rationale for use
  • Guanfacine XR - positive and side effects, rationale for use
Importance of early intervention in ADHD
  • Neuroprotective effects
Off label medications used for ADHD Factors involved in choosing which medication to use
  • Intervention context, patient characteristics, comorbidity
Conclusions
  • Evidence based treatments
  • Experimental psychosocial treatments
  • Nutritional interventions
  • Disproven therapies

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Marriage And Family Therapists
  • Speech-Language Pathologists
  • Teachers
  • School Administrators
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Nurses
  • Other Helping Professionals Who Work with Children

Reviews

5
4
3
2
1

Overall:      5

Total Reviews: 8

Comments

Jorge D - Gaithersburg, Maryland

"Dr. Barkley was very helpful, respectful and knowledgeable. "

Jo B - BELDEN, Mississippi

"Excellent presentation. "

Gregory M - Mountain Top, Pennsylvania

"Dr Barkley consistently delivers excellent trainings. I am always interested in anything he presents"

Mary Lou F - HIGHLAND HEIGHTS, Ohio

"The course was very thorough and detailed. The notes highlighted all of the major points. It was an honor to hear Dr. Barkley speak, as he is a forerunner in the field."

Andrea R - San Diego, California

"Excellent lecture answered many of my questions!"

Joanne S - Brisbane, Qld

"excellent and very useful!"

Jennifer G - SIOUX FALLS, South Dakota

"I always learn a great deal from Dr. Barkley's presentations. I appreciate how concise he is with the information. I will most definitely choose more of his courses. "

Zachary M - SHERMAN OAKS

"The course was material was eloquently delivered and Dr. Barkley as always was amazing in his breadth and depth of knowledge on the material."

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or email info@pesi.com.au.

Please wait ...

Back to Top